| Application no. and date | 19208417.6 (espacenet) (Federated) (European Patent Register), 20191111 | | Patent/reg. no. and date | DK/EP 3819007, 20240710 | | Publication date | 20210512 | | Priority no. and date | | | EP pub. no. and date |
EP 3819007 20210512 | | Effective date | | | Applicant/owner | Amgen Inc., One Amgen Center Drive
Thousand Oaks, CA 91320, US,
Amgen Research (Munich) GmbH, Staffelseestrasse 2
81477 München, DE | | Applicant ref. no. | 1694884 | | Inventor | Stieglmaier, Julia, c/o Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 München, DE,
Huber, Birgit, c/o Amgen Research (Munich) GmbH
Staffelseestrasse 2
81477 München, DE,
Minella, Alexander, c/o Amgen Inc
One Amgen Center Drive
Thousand Oaks, CA 91320, US,
Upreti, Vijay, c/o Amgen Inc
One Amgen Center Drive
Thousand Oaks, CA 91320, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | DOSERINGSPLAN FOR ANTI-BCMA-MIDLER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
